Medicine and Dentistry
Radioembolization
100%
Yttrium 90
96%
Hepatocellular Carcinoma
85%
Neoplasm
51%
Microsphere
49%
Transcatheter Arterial Chemoembolization
27%
Liver Tumor
24%
Cancer
20%
Embolization
19%
Liver Metastasis
18%
Diseases
18%
Oncology
15%
Overall Survival
15%
Liver Cancer
14%
Magnetic Resonance Imaging
14%
Metastatic Carcinoma
13%
Portal Vein Thrombosis
11%
Liver Transplantation
10%
Hepatic Portal Vein
10%
Arterial Embolization
10%
Necrosis
9%
Adverse Event
9%
Malignant Neoplasm
9%
Interventional Radiology
8%
Perfusion Weighted Imaging
8%
Intraarterial Drug Administration
7%
Transjugular Intrahepatic Portosystemic Shunt
7%
Dosimetry
7%
Response Evaluation Criteria in Solid Tumors
7%
Bilirubin
7%
Colorectal Liver Metastasis
6%
Interventional Radiologist
6%
Segmentectomy
6%
Colorectal Carcinoma
6%
Cholangiocarcinoma
6%
Positron Emission Tomography
6%
Neuroendocrine Tumor
5%
Computer Assisted Tomography
5%
Inferior Vena Cava Filter
5%
Brachytherapy
5%
Hazard Ratio
5%
Quality of Life
5%
Albumin
5%
Keyphrases
Hepatocellular Carcinoma
75%
Radioembolization
68%
Yttrium-90 Radioembolization
41%
Yttrium-90 Microspheres
36%
Yttrium-90
26%
Tumor
22%
Liver
21%
Chemoembolization
18%
Intra-arterial
16%
Liver Tumor
14%
Transarterial Radioembolization
13%
Locoregional Therapy
13%
Overall Survival
11%
Portal Vein Thrombosis
11%
Liver Transplantation
11%
Tumor Response
11%
Unresectable Hepatocellular Carcinoma
11%
Transarterial Chemoembolization
11%
Magnetic Resonance Imaging
10%
Hepatic Malignancy
10%
Confidence Interval
10%
Necrosis
9%
Transcatheter
9%
Glass Microspheres
9%
TheraSphere
9%
Embolization
8%
Adverse Events
8%
Colorectal Liver Metastases
8%
Interventional Oncology
8%
Response Evaluation Criteria in Solid Tumors (RECIST)
8%
Transjugular Intrahepatic Portosystemic Shunt
7%
Interventional Radiology
7%
Resection
7%
Interventional Radiologist
7%
European Association for the Study of the Liver
7%
Liver Cancer
7%
Barcelona Clinic Liver Cancer
6%
Liver Metastasis
6%
Transarterial
6%
Intra-arterial Therapy
6%
Perfusion Magnetic Resonance Imaging
6%
Radiation Segmentectomy
6%
VX2 Tumor
6%
Dosimetry
6%
Time to Progression
6%
Patient Cohort
5%
Hepatocellular Carcinoma Patients
5%
Lobar
5%
Hepatic Metastasis
5%
Chemotherapy
5%